Table 3.
Unadjusted and Adjusted Analysis between IBD status and CRC
| Table 3a | Unadjusted | Adjusted* | ||
|---|---|---|---|---|
| Odds Ratio(CI) |
p-value |
Odds Ratio(CI) |
p-value |
|
| IBD | 1.91(1.12,3.26) | 0.018 | 1.88(1.08,3.26) | 0.025 |
| Statin | 0.48(0.38,0.61) | <.001 | 0.55(0.43,0.7) | <.001 |
| NSAID/ASA | 0.60(0.51,0.70) | <.001 | 0.62(0.53,0.74) | <.001 |
| Table 3b | Unadjusted | Adjusted* | ||
|---|---|---|---|---|
| Odds Ratio (CI) |
p-value |
Odds Ratio(CI) |
p-value |
|
| IBD | 2.25(1.25, 4.06) | 0.007 | 2.19(1.2, 3.97) | 0.010 |
| Statin | 0.49(0.39, 0.62) | <.001 | 0.56(0.44, 0.72) | <.001 |
| IBD * statin | 0.17(0.02, 1.62) | 0.124 | 0.19(0.02, 1.86) | 0.154 |
| IBD | 1.93(1.06, 3.51) | 0.032 | 1.90(1.04, 3.50) | 0.038 |
| NSAID/ASA | 0.59(0.51, 0.7) | <.001 | 0.62(0.53, 0.74) | <.001 |
| IBD * NSAID/ASA | 0.79(0.2, 3.17) | 0.743 | 0.93(0.22, 3.89) | 0.920 |
*
Analyses adjusted for age, ethnicity, vegetable consumption, history of colorectal cancer in first-degree relative, sports participation and smoking status. CI denotes 95% confidence interval.